Dr. Smita Shenoy
Professor
Reg.No:69671
Department of Pharmacology
Qualification: MBBS, MD (Karnataka Medical Council registration number: 69671)
CURRENT ACADEMIC ROLE & RESPONSIBILITIES
She:
o Trains undergraduate and post graduate students
o Guides undergraduates, postgraduates and PhD scholars
o Is a member of internal quality assurance cell, career guidance cell and pharmacovigilance?committee
SUBJECTS CURRENTLY TEACHING
| Subject | Semester / Year |
|---|---|
| Pharmacology | 2nd year MBBS |
| Pharmacology MD: PGY1, PGY2 and PGY3 | 1st-3rd year MD |
ACADEMIC QUALIFICATIONS
| Degree | Specialisation | Institute | Year of passing |
|---|---|---|---|
| MD | Pharmacology | Kasturba Medical College, 365体育投注 | 2003 |
| MBBS | North Bengal Medical College, Sushrutanagar | 1993 |
Experience
| Institution / Organisation | Designation | Role | Tenure |
|---|---|---|---|
| KMC,365体育投注 | Professor | Administrative, training and guiding UGs, PGs and PhD research scholars, conduct research | 01.12.2019- Till date |
| KMC,365体育投注 | Professor and Head | Administrative, training and guiding UGs, PGs and PhD research scholars, conduct research | 01.12.2019- 30.11.2024 |
| KMC, 365体育投注 | Associate Professor | Administrative, training and guiding UGs and PGs, conduct research | 04.03.2009-30.11.2019 |
| KMC, 365体育投注 | Assistant Professor | Training and guiding UGs and PGs, conduct research | 04.03.2004-03.03.2009 |
| KMC, 365体育投注 | Tutor | Training UGs, conduct research | 01.01.2001-31.12.2003 |
AREAS OF INTEREST, EXPERTISE AND RESEARCH
Area of Interest
Basic and clinical pharmacology
Area of Expertise
Neuropharmacology, Traditional medicines, HIV, toxicity studies
Area of 365体育投注
Neurodevelopmental toxicity, traditional medicines in hepatic diseases and psoriasis, drug-drug interactions, adverse drug reactions
Professional Affiliations & Contributions
- Member of Indian Pharmacological Society
- Member of Institutional Ethics Committee, KMC & KH (2016 – 2018)
- Coordinator, Quality cell, KMC 365体育投注, Oct 2017 – Feb 2019.
- Member Secretary, Institutional Animal Ethics Committee, KMC 365体育投注 , 2017-2022
- Study coordinator for clinical trials???
Books
o? ?Pharmacology for Medical graduates: (Elsevier) 5th?edition 2022
????????????? ???????????????Tara Shanbhag, Smita Shenoy
o? ?Pharmacology for Nurses: (Elsevier) 3rd ?edition 2023
?????????????? ??????????????Tara Shanbhag, Smita Shenoy, Veena Nayak
Chapter
o?? Lal SM, Kamath A, Parida A, Shenoy S.??Nanopharmacokinetics assessment. In: Thorat ND, Kumar N, eds.??Nano-pharmacokinetics and theranostics. 1st?ed. London: Academic Press (imprint of Elsevier); 2021.p.171-92.??
1. Kumar S., Shenoy S, Swamy RS, Ravichandiran V, Kumar N. Fluoride-Induced Mitochondrial Dysfunction and Approaches for Its Intervention. Biological Trace Element 365体育投注 2024; 202(3): 835–49.
2. Abhijna Ballal R , Shivakumar Reddy K , Divya Chandran , Sumukha Hegde , Raghavendra Upadhya , Praveen Kumar SE , Smita Shenoy , Vasudha Devi and Dinesh Upadhya. Cell-specific extracellular vesicle-encapsulated exogenous GABA controls seizures in epilepsy. Stem Cell 365体育投注 & Therapy. Dec 2024; 15(1):108.
3. Ashwija Kolakemar, Shivaprakash Gangachannaiah, Sadhana N Holla, Mohandas Rao KG, Smita Shenoy, Rajashekar Chinta, Chetan Hasmukh Mehta, Usha Yogendra Nayak. Sphingosine-1-Phosphate Receptor Modulator – Siponimod: An Evaluation to Ameliorate Aluminium Chloride Induced Behavioural Change and Biochemical effects. 365体育投注 Journal of Pharmacy and Technology. 2024; 17(1):179-7.
4.?Kumar S,?Chhabra V,?Mehra M,Saranya K, Kumar BH, Shenoy S, Swamy RS,?Pai KM, Pai KSR,?Kumar N.?The fluorosis conundrum: bridging the gap between science and public health. Toxicology Mechanisms and Methods?2024; 34(2): 214–35.
5.?Kumar, S.,?Chhabra, V.,?Shenoy, S.,?Daksh R, Ravichandiran V, Swamy, R.S.,?Kumar, N. Role of Flavonoids in Modulation of Mitochondria Dynamics during Oxidative Stress. Mini-Reviews in Medicinal Chemistry.?2024; 24(9): 908–19.
1. The effect of ketamine on behaviors of Drosophila melanogaster with depression-like state.
2. Off label prescribing in cancer patients
3. Drug – drug interactions in palliative care
4. Sirtuins in fluoride induced toxicity